PD-L1-positive Immune Cells May Help to Predict Survival Rates in EPMM, Study Says
News
A study that looked into France’s RENAPE Observational Registry, a database of rare peritoneal tumors, found that the presence of programmed death-ligand 1 (PD-L1) on immune cells in epithelioid peritoneal ... Read more
4 Possible Experimental Treatments for Mesothelioma
Could Cannabis Help People With Lung Diseases?
Combining Immunotherapy, Accelerated Radiation and Surgery Bolsters Immune Response Against Mesothelioma, Study Shows
News
Combining immunotherapy, accelerated radiation and surgery can improve immune system response against malignant pleural mesothelioma, according to a study. Immunotherapies for solid tumors have become a major focus of cancer research, ... Read more
New Way to Promote Cell Death Could Lead to Better Mesothelioma Therapies, Study Reports
News
Activating a new mechanism to promote cell death could provide hope for better mesothelioma treatments, a Japanese study indicates. The research, ”Connexin 43 enhances Bax activation via JNK activation in ... Read more
Why Veterans Have Such a High Risk of Developing Mesothelioma
How Mesothelioma Develops in Children and Young Adults
Zoledronic Acid Could Be a Mesothelioma Add-On Treatment, Researchers Contend After Pilot Study
News
Zoledronic acid was only modestly active as a stand-alone therapy for advanced malignant pleural mesothelioma in a small Phase 2 pilot clinical trial. But researchers argue that its properties make ... Read more
TCR²’s Engineered Immune T-Cells Outperform More Common Class of Cells Against Mesothelioma, Studies Show
News
A key approach to treating cancer these days is engineering immune T-cells to produce receptors on their surfaces that recognize cancer, so that the T-cells can attack it. One engineering ... Read more